Overview

Beta-Cell Function After Near-Normalisation of Blood Glucose

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The incretin effect is attenuated in patients with type 2 diabetes mellitus partly due to impaired potentiation of beta-cell responsiveness to glucose by glucose dependent insulinotropic polypeptide and glucagon-like peptide-1 respectively. The aim of the present study was to investigate whether 4 weeks of near-normalization of blood glucose could improve the insulin responses to GIP and GLP-1 in patients with type 2 diabetes.
Phase:
N/A
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Gastric Inhibitory Polypeptide
Glucagon
Glucagon-Like Peptide 1